ANTONIJOAN ARBOS, ROSA MARIA FGS
rantonijoana@santpau.cat
Ayala Oliveros, Johan Humberto IR
Castillo Ocaña, Marta IR
Coimbra Hurtado, Maria Jimena IR
Cuadro Bertolin, David IR
Funes Ungria, Maria Angels IR
Garrido Sanchez, Maria Teresa IR
Gomis Pulgar, Ana Maria IR
Gonzalez Gomez, Luis IR
Martinez Bonifacio, David IR
Martinez Colomer, Juan IR
Martinez Dominguez, Pura IR
Martinez Martinez, Maria Isabel IR
Mercader Segui, Esteve IR
Molina Perello, Pol IR
Peri Laviga, Jordi IR
Puntes Rodriguez, Montserrat IR
Sanchez Nuñez, Isabel IR
Serra, Laura IR
Alvarez G., Sola I., Sitja-Rabert M., Fort-Vanmeerhaeghe A., Gich I., Fernandez C., Bonfill X., Urrutia G. (2020) A methodological review revealed that reporting of trials in manual therapy has not improved over time. J CLIN EPIDEMIOL, 121 (), 32-44. IF: 6,4370
Bollo J., Turrado V., Rabal A., Carrillo E., Gich I., Martinez M.C., Hernandez P., Targarona E. (2020) Randomized clinical trial of intracorporeal versus extracorporeal anastomosis in laparoscopic right colectomy (IEA trial). BRIT J SURG, 107 (4), 364-372. IF: 6,9390
Cassado J., Simo M., Rodriguez N., Porta O., Huguet E., Mora I., Girvent M., Fernandez R., Gich I. (2020) Prevalence of levator ani avulsion in a multicenter study (PAMELA study). ARCH GYNECOL OBSTET, 302 (1), 273-280. IF: 2,3440
Corrochano M., Jimenez B., Millon J., Gich I., Rambla M., Gil E., Caparros P., Macho R., Souto J.C. (2020) Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: Clinical outcomes in a single centre cohort after long-term follow-up. BMC CARDIOVASC DISOR, 20 (1), 166-. IF: 2,2980
Garcia-Patterson A., Ovejero D., Minambres I., Chico A., Gil P.A., Martinez M.-J., Adelantado J.M., de Leiva A., Gich I., Desoye G., de Mouzon S.H., Corcoy R. (2020) Both glycaemic control and insulin dose during pregnancy in women with type 1 diabetes are associated with neonatal anthropometric measures and placental weight. DIABETES-METAB RES, (), -. IF: 4,8760
Molto C., Hwang T.J., Borrell M., Andres M., Gich I., Barnadas A., Amir E., Kesselheim A.S., Tibau A. (2020) Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration. CANCER-AM CANCER SOC, 126 (19), 4390-4399. IF: 6,8600
Riudavets M., Mosquera J., Garcia-Campelo R., Serra J., Anguera G., Gallardo P., Sullivan I., Barba A., del Carpio L., Barnadas A., Gich I., Majem M. (2020) Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents. FRONT ONCOL, 10 (), -. IF: 6,2440